MiR-126 has been widely reported as a tumour suppressor in lung cancer due to targeting IRS1, EGFL7, Crk, and SLC7A51318, or by means of inhibiting angiogenesis and lung metastasis during lung cancer28,29. This evidence concerns the gene EGFL7 and lung carcinoma.